Christine Rothe

1.4k total citations
15 papers, 920 citations indexed

About

Christine Rothe is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Christine Rothe has authored 15 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Christine Rothe's work include Monoclonal and Polyclonal Antibodies Research (12 papers), CAR-T cell therapy research (6 papers) and Protein purification and stability (5 papers). Christine Rothe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), CAR-T cell therapy research (6 papers) and Protein purification and stability (5 papers). Christine Rothe collaborates with scholars based in Germany, Switzerland and United States. Christine Rothe's co-authors include Arne Skerra, Robert Rauchenberger, Françoise Gerber, Walter Huber, Jürg Messer, Jörg Benz, Hansruedi Loetscher, Christer Nordstedt, Bernd Bohrmann and W. Richter and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Christine Rothe

15 papers receiving 873 citations

Peers

Christine Rothe

RNMI

PHYSI

PHARM

CTM

Anne V. Thomas United States

Christopher Fisher United States

Kyle G. Howell United States

Galia Maik-Rachline Israel

Francella J. Otero United States

Kazumi Hayashi Japan

Ulrich Göpfert Germany

Anastasia Velentza United States

Zhao Yang China

Corinne Leprince France

Anne V. Thomas United States

Christine Rothe

314 ×0.6

105 ×0.3

RNMI

265 ×0.9

PHYSI

50 ×0.4

PHARM

31 ×0.3

CTM

Citations per year, relative to Christine Rothe Christine Rothe (= 1×) peers Anne V. Thomas

Countries citing papers authored by Christine Rothe

Since Specialization

Citations

This map shows the geographic impact of Christine Rothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Rothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Rothe more than expected).

Fields of papers citing papers by Christine Rothe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Rothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Rothe. The network helps show where Christine Rothe may publish in the future.

Co-authorship network of co-authors of Christine Rothe

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Rothe. A scholar is included among the top collaborators of Christine Rothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Rothe. Christine Rothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Morales‐Kastresana, Aizea, et al.. (2022). Anticalin®-based therapeutics: Expanding new frontiers in drug development. International review of cell and molecular biology. 369. 89–106. 2 indexed citations

Siegemund, Martin, Prajakta Oak, Alexandra Winter, et al.. (2021). Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains. Frontiers in Pharmacology. 12. 759337–759337. 6 indexed citations

Morales‐Kastresana, Aizea, Janet K. Peper-Gabriel, Lucia Pattarini, et al.. (2021). Abstract LB135: Simultaneous costimulatory T-cell engagement and checkpoint inhibition by PRS-344/S095012, a PD-L1/4-1BB bispecific compound for tumor localized activation of the immune system. Cancer Research. 81(13_Supplement). LB135–LB135. 1 indexed citations

Rothe, Christine & Arne Skerra. (2018). Anticalin® Proteins as Therapeutic Agents in Human Diseases. BioDrugs. 32(3). 233–243. 75 indexed citations

Hinner, Marlon J., Thomas J. Jaquin, Sven Berger, et al.. (2017). Abstract 3673: Preclinical toxicology and pharmacology for the 4-1BB/HER2 bispecific PRS-343: A first-in-class costimulatory T cell engager. Cancer Research. 77(13_Supplement). 3673–3673. 2 indexed citations

Hinner, Marlon J., Corinna Schlosser, Thomas J. Jaquin, et al.. (2016). Abstract B016: Costimulatory T-cell engagement by PRS-343, a CD137 (4-1BB)/HER2 bispecific, leads to tumor growth inhibition and TIL expansion in humanized mouse model. Cancer Immunology Research. 4(11_Supplement). B016–B016. 1 indexed citations

Hinner, Marlon J., Corinna Schlosser, Thomas J. Jaquin, et al.. (2016). Costimulatory T-cell engagement by PRS-343, a CD137 (4-1BB)/HER2 bispecific, leads to tumor growth inhibition and TIL expansion in a humanized mouse model. European Journal of Cancer. 69. S99–S99. 9 indexed citations

Hinner, Marlon J., Corinna Schlosser, Alexander Wiedenmann, et al.. (2016). Abstract 556: Costimulatory T-cell engagement by the HER2/CD137 bispecific PRS-343 leads to strong antitumor effect in humanized mouse model. Cancer Research. 76(14_Supplement). 556–556. 2 indexed citations

Hinner, Marlon J., Alexander Wiedenmann, Corinna Schlosser, et al.. (2015). Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein. Journal for ImmunoTherapy of Cancer. 3(S2). 11 indexed citations

10.

Bohrmann, Bernd, Karlheinz Baumann, Jörg Benz, et al.. (2012). Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β. Journal of Alzheimer s Disease. 28(1). 49–69. 328 indexed citations

11.

Schwarz, Christina, et al.. (2011). Effects of different media on proliferation and differentiation capacity of canine, equine and porcine adipose derived stem cells. Research in Veterinary Science. 93(1). 457–462. 44 indexed citations

12.

Rothe, Christine, Stefanie Urlinger, Josef Prassler, et al.. (2008). The Human Combinatorial Antibody Library HuCAL GOLD Combines Diversification of All Six CDRs According to the Natural Immune System with a Novel Display Method for Efficient Selection of High-Affinity Antibodies. Journal of Molecular Biology. 376(4). 1182–1200. 183 indexed citations

13.

Rauchenberger, Robert, Eric Borges, Eran Rom, et al.. (2003). Human Combinatorial Fab Library Yielding Specific and Functional Antibodies against the Human Fibroblast Growth Factor Receptor 3. Journal of Biological Chemistry. 278(40). 38194–38205. 91 indexed citations

14.

Krebs, Barbara, Robert Rauchenberger, Silke U. Reiffert, et al.. (2001). High-throughput generation and engineering of recombinant human antibodies. Journal of Immunological Methods. 254(1-2). 67–84. 130 indexed citations

15.

Rothe, Christine & Ludwig Lehle. (1998). Sorting of invertase signal peptide mutants in yeast dependent and independent on the signal‐recognition particle. European Journal of Biochemistry. 252(1). 16–24. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact